Cart
sales@molnova.com
Praliciguat
CAS No. 1628730-49-3
Praliciguat( IW-1973 )
Catalog No. M26793 CAS No. 1628730-49-3
Praliciguat stimulates sGC in HEK-293 cells (EC50: 197 nM). Praliciguat is an effective and orally active soluble guanylate cyclase stimulator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 432 | In Stock |
|
| 2MG | 218 | In Stock |
|
| 5MG | 368 | In Stock |
|
| 10MG | 567 | In Stock |
|
| 25MG | 905 | In Stock |
|
| 50MG | 1200 | In Stock |
|
| 100MG | 1609 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePraliciguat
-
NoteResearch use only, not for human use.
-
Brief DescriptionPraliciguat stimulates sGC in HEK-293 cells (EC50: 197 nM). Praliciguat is an effective and orally active soluble guanylate cyclase stimulator.
-
DescriptionPraliciguat stimulates sGC in HEK-293 cells (EC50: 197 nM). Praliciguat is an effective and orally active soluble guanylate cyclase stimulator. It also enhances NO signaling and acts as a vasodilator.
-
In Vitro——
-
In Vivo——
-
SynonymsIW-1973
-
PathwayOthers
-
TargetOther Targets
-
RecptorAlkyl/ether| Cleavable| PEGs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1628730-49-3
-
Formula Weight534.37
-
Molecular FormulaC21H14F8N6O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (467.85 mM)
-
SMILESOC(CNc1nc(ncc1F)-c1cc(-c2ccon2)n(Cc2ccccc2F)n1)(C(F)(F)F)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Carston R. Wagner, et al. Protein nanorings. US8236925B1.
molnova catalog
related products
-
4-Borono-L-phenylala...
4-Borono-L-phenylalanine has antitumor activity and may be used in clinical trials of boron neutron capture therapy for the treatment of melanoma and glioblastoma multiforme.
-
Pyr-Trp-OEt
Pyr-Trp-OEt
-
Dehydrocrenatidine
Dehydrocrenatidine, a natural alkaloid, is a specific JAK inhibitor. Dehydrocrenatidine inhibits voltage-gated sodium channels and ameliorates mechanic allodia in a rat model of neuropathic pain.
